| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 5,139 | 6,095 | 5,095 | 4,899 | | Cost of Revenue | 2,921 | 2,622 | 4,313 | 2,460 | | | Gross Profit | 2,218 | 3,473 | 782 | 2,439 | | | Operating Expenses | | Research Development | 2,839 | 2,808 | 2,780 | 3,004 | | Selling General and Administrative | 3,888 | 3,694 | 3,905 | 3,632 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 7 | 18 | 24 | 24 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,516) | (3,047) | (5,927) | (4,221) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 44 | (693) | (3,201) | 344 | | Earnings Before Interest And Taxes | (4,472) | (3,740) | (9,128) | (3,877) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (4,472) | (3,740) | (9,128) | (3,877) | | Income Tax Expense | 14 | 33 | (112) | (86) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,486) | (3,773) | (9,016) | (3,791) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,486) | (3,773) | (9,016) | (3,791) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,486) | ($3,773) | ($9,016) | ($3,791) |
|
0.19% Nasdaq 
Income Statement
